Get started
222

CUTIA THERAPEUTICS

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

2487 chart


Full chart

2487 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.13 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.86 HKD
Net income (FY)
‪−2.17 B‬ HKD
Revenue (FY)
‪152.07 M‬ HKD
Shares float
‪88.33 M‬
Beta (1Y)
0.86

Employees


Employees (FY)
298
Change (1Y)
+295 +9,833.33%
Revenue / Employee (1Y)
‪65.34 K‬ HKD
Net income / Employee (1Y)
‪−932.28 K‬ HKD

About CUTIA THERAPEUTICS


Sector
Health Technology
CEO
Le Le Zhang
Headquarters
Shanghai
Website
cutiatx.com
Founded
2019
FIGI
BBG01GVKT2Y1
Cutia Therapeutics is a holding company, which engages in the research and development of dermatology treatment solutions and products through its subsidiaries. Its product portfolios include scalp diseases and care, skin diseases and care, localized adipose accumulation management medication, and topical anesthesia. The company was founded by Le Le Zhang on May 15, 2019 and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

2487 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2487 is 9.78 HKD — it has decreased by −6.76% in the past 24 hours. Watch CUTIA THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CUTIA THERAPEUTICS stocks are traded under the ticker 2487.
2487 stock has fallen by −26.94% compared to the previous week, the month change is a −20.28% fall, over the last year CUTIA THERAPEUTICS has showed a −53.38% decrease.
We've gathered analysts' opinions on CUTIA THERAPEUTICS future price: according to them, 2487 price has a max estimate of 15.19 HKD and a min estimate of 14.23 HKD. Watch 2487 chart and read a more detailed CUTIA THERAPEUTICS stock forecast: see what analysts think of CUTIA THERAPEUTICS and suggest that you do with its stocks.
2487 reached its all-time high on Jun 16, 2023 with the price of 32.60 HKD, and its all-time low was 5.58 HKD and was reached on Feb 5, 2024. View more price dynamics on 2487 chart.
See other stocks reaching their highest and lowest prices.
2487 stock is 12.03% volatile and has beta coefficient of 0.86. Track CUTIA THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is CUTIA THERAPEUTICS there?
Today CUTIA THERAPEUTICS has the market capitalization of ‪2.98 B‬, it has decreased by −0.16% over the last week.
Yes, you can track CUTIA THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
CUTIA THERAPEUTICS is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
2487 net income for the last half-year is ‪−217.73 M‬ HKD, while the previous report showed ‪−349.40 M‬ HKD of net income which accounts for 37.69% change. Track more CUTIA THERAPEUTICS financial stats to get the full picture.
No, 2487 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 298.00 employees. See our rating of the largest employees — is CUTIA THERAPEUTICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CUTIA THERAPEUTICS EBITDA is ‪−543.03 M‬ HKD, and current EBITDA margin is −361.26%. See more stats in CUTIA THERAPEUTICS financial statements.
Like other stocks, 2487 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CUTIA THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CUTIA THERAPEUTICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CUTIA THERAPEUTICS stock shows the strong sell signal. See more of CUTIA THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.